CRP and myocardial infarction: Circulating biomarkers of CVDs, like total cholesterol and low-density lipoproteins (LDL), and prognostic biomarkers for myocardial infarction (MI), like creatine kinase MB, high-sensitivity cardiac troponin, and high-sensitivity C-reactive protein, can only give a ballpark estimate of the likelihood that the disease will develop and progress [74].